Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study

International Journal of Urology, EarlyView.

Source: International Journal of Urology - July 15, 2018 Category: Urology & Nephrology Authors: Vasileios Sakalis , Vasileios Sfiggas , Ioannis Vouros , George Salpiggidis , Athanasios Papathanasiou , Apostolos Apostolidis Source Type: research